|
HY-N6085-1mg
|
MedChemexpress LLC
|
N-?Caffeoylputrescine,?(E)?- [CAS 29554-26-5]
|
|
|
|
|
HY-N6085-5mg
|
MedChemexpress LLC
|
N-?Caffeoylputrescine,?(E)?- [CAS 29554-26-5]
|
|
|
|
|
HY-W127487-10mg
|
MedChemexpress LLC
|
N-Octadecanoyl-L-homoserine lactone [CAS 479050-96-9]
|
|
|
|
|
HY-N5099-1mg
|
MedChemexpress LLC
|
N-Vanillyldecanamide [CAS 31078-36-1]
|
|
|
|
|
HY-N5099-10mg
|
MedChemexpress LLC
|
N-Vanillyldecanamide [CAS 31078-36-1]
|
|
|
|
|
HY-N5099-25mg
|
MedChemexpress LLC
|
N-Vanillyldecanamide [CAS 31078-36-1]
|
|
|
|
|
HY-N5099-5mg
|
MedChemexpress LLC
|
N-Vanillyldecanamide [CAS 31078-36-1]
|
|
|
|
|
HY-N5099-50mg
|
MedChemexpress LLC
|
N-Vanillyldecanamide [CAS 31078-36-1]
|
|
|
|
|
HY-N0308-10g
|
MedChemexpress LLC
|
Octyl acetate [CAS 112-14-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0308-5g
|
MedChemexpress LLC
|
Octyl acetate [CAS 112-14-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7400-1mg
|
MedChemexpress LLC
|
Phaseoloidin [CAS 118555-82-1]
|
|
|
|
|
HY-N7400-10mg
|
MedChemexpress LLC
|
Phaseoloidin [CAS 118555-82-1]
|
|
|
|
|
HY-N7400-5mg
|
MedChemexpress LLC
|
Phaseoloidin [CAS 118555-82-1]
|
|
|
|
|
HY-D0803-100mg
|
MedChemexpress LLC
|
Thymoquinone [CAS 490-91-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-D0803-1mL
|
MedChemexpress LLC
|
Thymoquinone [CAS 490-91-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N0367-100g
|
MedChemexpress LLC
|
Trans-Anethole [CAS 4180-23-8]
|
|
Cancer-programmed cell death
|
|
|
HY-N0367-50g
|
MedChemexpress LLC
|
Trans-Anethole [CAS 4180-23-8]
|
|
Cancer-programmed cell death
|
|
|
HY-N0367-1mL
|
MedChemexpress LLC
|
Trans-Anethole [CAS 4180-23-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
228-11921-2
|
RayBiotech, Inc.
|
Activin A, Human Recombinant, Plant
|
|
|
|
|
228-11922-2
|
RayBiotech, Inc.
|
Growth Hormone, Human Recombinant, Plant
|
|
|
|
|
228-11926-2
|
RayBiotech, Inc.
|
Activin-B, Human Recombinant, Active
|
|
|
|
|
228-11927-2
|
RayBiotech, Inc.
|
Activin-B, Human Recombinant
|
|
|
|
|
228-20075-2
|
RayBiotech, Inc.
|
BAFF (BLyS), Human Recombinant, Plant
|
|
|
|
|
230-00066-10
|
RayBiotech, Inc.
|
Recombinant Oryza sativa subsp. Japonica Ory s 12
|
|
|
|
|
230-00926-10
|
RayBiotech, Inc.
|
Recombinant Oryza Sativa Subsp. Japonica Ory s 1
|
|
|
|
